List of Tables
Table 1. Global Antiemetics for Cancer Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Antiemetics for Cancer Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Antiemetics for Cancer Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Antiemetics for Cancer Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Antiemetics for Cancer Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Antiemetics for Cancer Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Antiemetics for Cancer Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Antiemetics for Cancer Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Antiemetics for Cancer Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antiemetics for Cancer Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antiemetics for Cancer Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Antiemetics for Cancer Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antiemetics for Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiemetics for Cancer Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antiemetics for Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Antiemetics for Cancer Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Antiemetics for Cancer Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Antiemetics for Cancer Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Antiemetics for Cancer Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Antiemetics for Cancer Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Antiemetics for Cancer Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Antiemetics for Cancer Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Antiemetics for Cancer Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Antiemetics for Cancer Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Antiemetics for Cancer Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Antiemetics for Cancer Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Antiemetics for Cancer Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Antiemetics for Cancer Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Antiemetics for Cancer Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Antiemetics for Cancer Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Antiemetics for Cancer Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Antiemetics for Cancer Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Antiemetics for Cancer Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Antiemetics for Cancer Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Antiemetics for Cancer Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Antiemetics for Cancer Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Antiemetics for Cancer Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Antiemetics for Cancer Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antiemetics for Cancer Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Antiemetics for Cancer Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Antiemetics for Cancer Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Antiemetics for Cancer Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antiemetics for Cancer Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Antiemetics for Cancer Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Antiemetics for Cancer Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Antiemetics for Cancer Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Antiemetics for Cancer Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Antiemetics for Cancer Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Antiemetics for Cancer Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Antiemetics for Cancer Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Antiemetics for Cancer Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Antiemetics for Cancer Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Antiemetics for Cancer Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Antiemetics for Cancer Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Antiemetics for Cancer Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Antiemetics for Cancer Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Antiemetics for Cancer Treatment Price (US$/Unit) by Type (2019-2024)
Table 59. Global Antiemetics for Cancer Treatment Price (US$/Unit) by Type (2025-2030)
Table 60. Global Antiemetics for Cancer Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Antiemetics for Cancer Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Antiemetics for Cancer Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Antiemetics for Cancer Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Antiemetics for Cancer Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Antiemetics for Cancer Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Antiemetics for Cancer Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Antiemetics for Cancer Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Antiemetics for Cancer Treatment Price (US$/Unit) by Application (2019-2024)
Table 69. Global Antiemetics for Cancer Treatment Price (US$/Unit) by Application (2025-2030)
Table 70. Heron Therapeutics, Inc Corporation Information
Table 71. Heron Therapeutics, Inc Description and Business Overview
Table 72. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Product
Table 74. Heron Therapeutics, Inc Recent Developments/Updates
Table 75. Sandoz International GmbH Corporation Information
Table 76. Sandoz International GmbH Description and Business Overview
Table 77. Sandoz International GmbH Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sandoz International GmbH Antiemetics for Cancer Treatment Product
Table 79. Sandoz International GmbH Recent Developments/Updates
Table 80. Merck & Co., Inc Corporation Information
Table 81. Merck & Co., Inc Description and Business Overview
Table 82. Merck & Co., Inc Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck & Co., Inc Antiemetics for Cancer Treatment Product
Table 84. Merck & Co., Inc Recent Developments/Updates
Table 85. Eisai Co., Ltd Corporation Information
Table 86. Eisai Co., Ltd Description and Business Overview
Table 87. Eisai Co., Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Eisai Co., Ltd Antiemetics for Cancer Treatment Product
Table 89. Eisai Co., Ltd Recent Developments/Updates
Table 90. Teva Pharmaceutical Industries Ltd Corporation Information
Table 91. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 92. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Product
Table 94. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 95. F. Hoffmann-La Roche Ltd Corporation Information
Table 96. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 97. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Product
Table 99. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 100. Mylan N.V Corporation Information
Table 101. Mylan N.V Description and Business Overview
Table 102. Mylan N.V Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Mylan N.V Antiemetics for Cancer Treatment Product
Table 104. Mylan N.V Recent Developments/Updates
Table 105. GSK plc Corporation Information
Table 106. GSK plc Description and Business Overview
Table 107. GSK plc Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. GSK plc Antiemetics for Cancer Treatment Product
Table 109. GSK plc Recent Developments/Updates
Table 110. Mundipharma International Corporation Information
Table 111. Mundipharma International Description and Business Overview
Table 112. Mundipharma International Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Mundipharma International Antiemetics for Cancer Treatment Product
Table 114. Mundipharma International Recent Developments/Updates
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Business Overview
Table 117. Baxter Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Baxter Antiemetics for Cancer Treatment Product
Table 119. Baxter Recent Developments/Updates
Table 120. Bayer AG Corporation Information
Table 121. Bayer AG Description and Business Overview
Table 122. Bayer AG Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Bayer AG Antiemetics for Cancer Treatment Product
Table 124. Bayer AG Recent Developments/Updates
Table 125. Cipla Inc Corporation Information
Table 126. Cipla Inc Description and Business Overview
Table 127. Cipla Inc Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Cipla Inc Antiemetics for Cancer Treatment Product
Table 129. Cipla Inc Recent Developments/Updates
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Sanofi Antiemetics for Cancer Treatment Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Sun Pharmaceutical Industries Ltd Corporation Information
Table 136. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 137. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Product
Table 139. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 140. Qilu Pharmaceutical Co.,Ltd Corporation Information
Table 141. Qilu Pharmaceutical Co.,Ltd Description and Business Overview
Table 142. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Product
Table 144. Qilu Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Antiemetics for Cancer Treatment Distributors List
Table 148. Antiemetics for Cancer Treatment Customers List
Table 149. Antiemetics for Cancer Treatment Market Trends
Table 150. Antiemetics for Cancer Treatment Market Drivers
Table 151. Antiemetics for Cancer Treatment Market Challenges
Table 152. Antiemetics for Cancer Treatment Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antiemetics for Cancer Treatment
Figure 2. Global Antiemetics for Cancer Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Antiemetics for Cancer Treatment Market Share by Type in 2023 & 2030
Figure 4. Serotonin Receptor Antagonists Product Picture
Figure 5. Neurokinin-1 Receptor Antagonist Product Picture
Figure 6. Corticosteroids Product Picture
Figure 7. Olanzapine Product Picture
Figure 8. Other Product Picture
Figure 9. Global Antiemetics for Cancer Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Antiemetics for Cancer Treatment Market Share by Application in 2023 & 2030
Figure 11. Highly Emetogenic Chemotherapy
Figure 12. Moderately Emetogenic Chemotherapy
Figure 13. Low Emetogenic Chemotherapy
Figure 14. Global Antiemetics for Cancer Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Antiemetics for Cancer Treatment Market Size (2019-2030) & (US$ Million)
Figure 16. Global Antiemetics for Cancer Treatment Sales (2019-2030) & (K Units)
Figure 17. Global Antiemetics for Cancer Treatment Average Price (US$/Unit) & (2019-2030)
Figure 18. Antiemetics for Cancer Treatment Report Years Considered
Figure 19. Antiemetics for Cancer Treatment Sales Share by Manufacturers in 2023
Figure 20. Global Antiemetics for Cancer Treatment Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Antiemetics for Cancer Treatment Players: Market Share by Revenue in 2023
Figure 22. Antiemetics for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Antiemetics for Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Antiemetics for Cancer Treatment Sales Market Share by Country (2019-2030)
Figure 25. North America Antiemetics for Cancer Treatment Revenue Market Share by Country (2019-2030)
Figure 26. United States Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Antiemetics for Cancer Treatment Sales Market Share by Country (2019-2030)
Figure 29. Europe Antiemetics for Cancer Treatment Revenue Market Share by Country (2019-2030)
Figure 30. Germany Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Antiemetics for Cancer Treatment Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Antiemetics for Cancer Treatment Revenue Market Share by Region (2019-2030)
Figure 37. China Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Antiemetics for Cancer Treatment Sales Market Share by Country (2019-2030)
Figure 45. Latin America Antiemetics for Cancer Treatment Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Antiemetics for Cancer Treatment Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Antiemetics for Cancer Treatment Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Antiemetics for Cancer Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Antiemetics for Cancer Treatment by Type (2019-2030)
Figure 55. Global Revenue Market Share of Antiemetics for Cancer Treatment by Type (2019-2030)
Figure 56. Global Antiemetics for Cancer Treatment Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Antiemetics for Cancer Treatment by Application (2019-2030)
Figure 58. Global Revenue Market Share of Antiemetics for Cancer Treatment by Application (2019-2030)
Figure 59. Global Antiemetics for Cancer Treatment Price (US$/Unit) by Application (2019-2030)
Figure 60. Antiemetics for Cancer Treatment Value Chain
Figure 61. Antiemetics for Cancer Treatment Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
